CDR2L anticorps (N-Term)

N° du produit ABIN927767

L’anticorps anti-CDR2L Polyclonal produit chez le Lapin a été validé pour WB. Il convient pour la détection de CDR2L dans des échantillons provenant de Humain. }

Aperçu rapide pour CDR2L anticorps (N-Term) (ABIN927767)

Antigène: CDR2L (Cerebellar Degeneration-Related Protein 2-Like (CDR2L))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CDR2L est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-CDR2L anticorps

Épitope: N-Term

Purification: Purified

Immunogène: CDR2 L antibody was raised in rabbit using the N terminal of CDR2 as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

CDR2L Blocking Peptide, (ABIN5612803), is also available for use as a blocking control in assays to test for specificity of this CDR2L antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur CDR2L

Antigène: CDR2L (Cerebellar Degeneration-Related Protein 2-Like (CDR2L))

Autre désignation: CDR2L

Sujet: The function of CDR2L remains unknown. Synonyms: Polyclonal CDR2L antibody, Anti-CDR2L antibody, cerebellar degeneration-related protein 2-like antibody, HUMPPA antibody.